enGene Holdings Inc. Files 8-K on Financials
Ticker: ENGNW · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1980845
Sentiment: neutral
Topics: 8-K, financial-condition, exhibits
TL;DR
enGene Holdings Inc. filed an 8-K on March 10, 2025, detailing financial condition and exhibits.
AI Summary
On March 10, 2025, enGene Holdings Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 4868 Rue Levy, Suite 220, Saint-Laurent, Quebec, Canada, H4R 2P1. The report pertains to Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
Why It Matters
This filing provides an update on enGene Holdings Inc.'s operational and financial status, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, providing standard corporate information without immediate significant financial events.
Key Players & Entities
- enGene Holdings Inc. (company) — Registrant
- March 10, 2025 (date) — Date of earliest event reported
- 4868 Rue Levy, Suite 220, Saint-Laurent, Quebec, Canada, H4R 2P1 (address) — Principal Executive Offices
- 001-41854 (company_id) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing for enGene Holdings Inc.?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition, as well as Financial Statements and Exhibits of enGene Holdings Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 10, 2025.
Where are enGene Holdings Inc.'s principal executive offices located?
enGene Holdings Inc.'s principal executive offices are located at 4868 Rue Levy, Suite 220, Saint-Laurent, Quebec, Canada, H4R 2P1.
What is the Commission File Number for enGene Holdings Inc.?
The Commission File Number for enGene Holdings Inc. is 001-41854.
What is the SIC code for enGene Holdings Inc.?
The Standard Industrial Classification (SIC) code for enGene Holdings Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding enGene Holdings Inc. (ENGNW).